West Pharmaceutical Services (STU:WPS) Net Income (Continuing Operations) : €456 Mil (TTM As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is West Pharmaceutical Services Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. West Pharmaceutical Services's Net Income (Continuing Operations) for the three months ended in Dec. 2024 was €124 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2024 was €456 Mil.

West Pharmaceutical Services Net Income (Continuing Operations) Historical Data

The historical data trend for West Pharmaceutical Services's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

West Pharmaceutical Services Net Income (Continuing Operations) Chart

West Pharmaceutical Services Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Income (Continuing Operations)

Get a 7-Day Free Trial

284.58

585.69

553.09

544.15

470.53

West Pharmaceutical Services Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Net Income (Continuing Operations)	Get a 7-Day Free Trial															125.63	106.08	103.40	122.54	124.25

West Pharmaceutical Services Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €456 Mil.

West Pharmaceutical Services (STU:WPS) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

West Pharmaceutical Services Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of West Pharmaceutical Services's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

West Pharmaceutical Services Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » West Pharmaceutical Services Inc (STU:WPS) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

WST:USA WST:Mexico WPS:Germany W2ST34:Brazil

Address

530 Herman O. West Drive, Exton, PA, USA, 19341-1147

Website

https://www.westpharma.com

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.